Results 51 to 60 of about 1,810,595 (288)
Electrocardiographic features of immune checkpoint inhibitor-associated myocarditis. [PDF]
, 2022 Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events including myocarditis, whilst improving cancer-related outcomes.
Song, Wenhua +10 more
core +1 more source
Pulmonary Circulation, 2021 Immunologic risk factors contribute to endothelial dysfunction and development of pulmonary vascular disease. Immune checkpoint inhibitors, used as immunotherapies for malignancies, have a wide range of reported immune-related adverse events.
Ruben Mylvaganam +6 more
doaj +1 more source
Operative management of immune checkpoint colitis following in-transit melanoma: Case report
Frontiers in Oncology, 2023 Immune checkpoint inhibitors are increasingly used as powerful anti-neoplastic therapies in the setting of melanoma. Colitis is a known complication of immune checkpoint inhibitors that if often medically managed.
Betzaira G. Childers +5 more
doaj +1 more source
Research Progress of Immune Checkpoint Inhibitors in Colorectal Cancer
Zhongliu Fangzhi Yanjiu, 2020 Tumor immunity is a new line of research for the treatment of patients with solid tumors, and negative regulators of the immune system called immune checkpoints play a key role in limiting antitumor immunologic responses.
ZHUANG Yuwen +3 more
doaj +1 more source
, 2022 Immunotherapy (IT) in the form of monoclonal antibodies targeting coreceptors involved in the modulation of the immune synapse represents a standard of care for patients with distinct malignancies.
Andréia Cristina de Melo +22 more
core +1 more source
Research Progress of Immune Checkpoint Therapy on Colorectal Cancer
Zhongliu Fangzhi Yanjiu, 2021 At present, immunotherapy is in full swing in the treatment of non-small cell lung cancer, melanoma, bladder cancer and other tumor species, and its treatment methods are also diverse, including tumor vaccine treatment, adoptive T cell therapy, immune ...
CAO Qihua, XU Yanbo, XU Dong
doaj +1 more source
Management of the Cardiovascular Adverse Effects of Immune Checkpoint Inhibitors
, 2023 With the rising use of immune checkpoint inhibitors in oncologic treatment, many so called immune related adverse events have been described. The guidelines regarding management of hepatitis, gastritis and dermatitis have been well discussed in ...
Elsaygh, Hassan Nabil
core
Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents
Безопасность и риск фармакотерапии, 2020 The introduction into clinical practice of immune checkpoint inhibitors that block cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein-1 (PD-1), and programmed cell death ligand-1 (PD-L1), has improved the prognosis of ...
E. V. Shubnikova +4 more
doaj +1 more source
Frontiers in Immunology, 2017 Immune checkpoint inhibitors, which target coinhibitory T cell molecules to promote anticancer immune responses, are on the rise to become a new pillar of cancer therapy.
Carmen Stecher +7 more
doaj +1 more source
Receipt of subsequent immune checkpoint inhibitors at progression among patients with solid tumors enrolled in clinical trials of adjuvant immune checkpoint inhibitors [PDF]
, 2022 : Purpose: Immune checkpoint inhibitors can induce long-term responses in metastatic cancer, thus determining how many patients on placebo control arms of adjuvant immune checkpoint inhibitors receive these drugs as standard of care at ...
Haslam, Alyson +2 more
core +1 more source